title: Modified acellularization for successful vascular xenotransplantation.
abstract: The purpose of this study was to estimate the possibilities of an acellular matrix using a modified acellularization protocol, which circumvents immunological, microbiological, and physiological barriers. We treated porcine subclavian arteries with various reagents to construct acellular grafts. Afterwards, these grafts were interposed in a mongrel dogs' abdominal aorta. Six dogs underwent interposition with fresh porcine grafts (control group), and seven had interposed acellular grafts (acellular group). The control and acellular group dogs were sacrificed at 1, 3, 5 (n=2 in each group) and 12 months (n=1 in acellular group) after the operation. Histopathological examinations were then performed, to assess the degree to which re-endothelialization, inflammation, thrombus formation, and calcification occurred. The entire acellular group, but none of the control group, exhibited re-endothelialization. The degrees to which inflammation, thrombosis, and calcification occurred were found to be lower in the acellular group. We also discovered many smooth muscle cells in the medial layer of the xenograft that had been implanted in the dog sacrificed 12 months after the operation. These results suggest that the construction of xenografts using our modified acellularization protocol may offer acceptable outcomes as a vascular xenograft.
authors: Department of Thoracic and Cardiovascular Surgery, Ansan Hospital, Korea University, Ansan, Korea.
authors: Won-Min
authors: WM
authors: Jo
authors: Young-sang
authors: YS
authors: Sohn
authors: Young Ho
authors: YH
authors: Choi
authors: Hark Jei
authors: HJ
authors: Kim
authors: Hyun Deuk
authors: HD
authors: Cho
mesh_terms: D000818:Animals; D002474:Cell-Free System / Q000637:transplantation*; D004285:Dogs; D006085:Graft Survival / Q000502:physiology*; D013348:Subclavian Artery / Q000166:cytology* / Q000637:transplantation*; D013552:Swine; D023822:Tissue Engineering / Q000379:methods*; D014183:Transplantation, Heterologous / Q000379:methods*